StonvexLoading…
StonvexStonvexStonvexCore line items from ROIV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $8.26M | $5.74M | $3.74M | $2.17M |
Operating Income | $-515.07M | $-930.31M | $-591.15M | $-284.92M |
Net Income | $-299.77M | $-602.76M | $-336.87M | $-223.35M |
EPS (Diluted) | $-0.54 | $-0.88 | $-0.49 | $-0.33 |
Total Assets | $5.71B | $5.23B | $5.06B | $5.03B |
Total Liabilities | $416.27M | $251.14M | $257.14M | $216.70M |
Cash & Equivalents | $1.42B | $1.48B | $1.24B | $1.24B |
Free Cash Flow OCF − CapEx | $-758.56M | $-593.48M | $-401.93M | $-208.42M |
Shares Outstanding | 720.35M | 709.69M | 689.70M | 682.23M |